Transitional Insight into the RNA-Based Oligonucleotides in Cancer Treatment

被引:0
|
作者
Tabasi, Hamed [1 ,2 ]
Mollazadeh, Samaneh [3 ]
Fazeli, Elham [4 ]
Abnus, Khalil [1 ]
Taghdisi, Seyed Mohammad [2 ]
Ramezani, Mohammad [1 ,2 ]
Alibolandi, Mona [1 ,2 ]
机构
[1] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Pharmaceut Res Ctr, Mashhad, Iran
[2] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmaceut Biotechnol, Mashhad, Iran
[3] North Khorasan Univ Med Sci, Nat Prod & Med Plants Res Ctr, Bojnurd, Iran
[4] Aarhus Univ, Biomed Dept, Aarhus, Denmark
关键词
Oligonucleotide; siRNA; miRNA; mRNA; Cancer-therapy; Immunotherapy; MESOPOROUS SILICA NANOPARTICLES; TARGETED SIRNA DELIVERY; CO-DELIVERY; STAT3; SIRNA; MIRNA OLIGONUCLEOTIDE; EFFICIENT DELIVERY; DOWN-REGULATION; DRUG-DELIVERY; COLON-CANCER; LUNG-CANCER;
D O I
10.1007/s12010-023-04597-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Conventional cancer therapies with chemodrugs suffer from various disadvantages, such as irreversible side effects on the skin, heart, liver, and nerves with even fatal consequences. RNA-based therapeutic is a novel technology which offers great potential as non-toxic, non-infectious, and well-tolerable platform. Herein, we introduce different RNA-based platforms with a special focus on siRNA, miRNA, and mRNA applications in cancer treatment in order to better understand the details of their therapeutic effects. Of note, the co-delivery of RNAs with other distinct RNA or drugs has provided safe, efficient, and novel treatment modalities for cancer treatment. [GRAPHICS] .
引用
收藏
页码:1685 / 1711
页数:27
相关论文
共 50 条
  • [21] RNA-based therapies
    Nature Biotechnology, 2023, 41 : 1071 - 1071
  • [22] Profiling of multiple RNA-based biomarkers for cancer identification
    Tian, Song
    Xu, Hong
    Ranjbar, Mohammad Nezami
    Reinecke, Frank
    Gu, Xiujing
    Padmanabhan, Raghavendra
    Deng, Jixin
    DiCarlo, John
    Winter, Scott
    Keller, James
    Quellhorst, George
    Kim, Young Woo
    Heard, Dan
    Samara, Raed
    Lader, Eric
    CANCER RESEARCH, 2020, 80 (16)
  • [23] Novel RNA-based Cancer Vaccine for AML immunotherapy
    Liu, Haiyan
    Tham, Guo Hong
    Ren, Xi
    Yang, Henry
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [24] RNA-based therapies
    Nature Biotechnology, 2019, 37 : 129 - 129
  • [25] RNA-based reprogramming
    Baker, Monya
    NATURE METHODS, 2011, 8 (01) : 18 - 18
  • [26] RNA-Based Liquid Biopsy in Head and Neck Cancer
    Kabzinski, Jacek
    Kucharska-Lusina, Aleksandra
    Majsterek, Ireneusz
    CELLS, 2023, 12 (14)
  • [27] The use of RNA-based treatments in the field of cancer immunotherapy
    Chehelgerdi, Mohammad
    Chehelgerdi, Matin
    MOLECULAR CANCER, 2023, 22 (01)
  • [28] RNA-based therapies
    Melnikova, Irena
    NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (11) : 863 - 864
  • [29] RNA-based vaccines
    Ulmer, Jeffrey B.
    Mason, Peter W.
    Geall, Andrew
    Mandl, Christian W.
    VACCINE, 2012, 30 (30) : 4414 - 4418
  • [30] RNA-based reprogramming
    Monya Baker
    Nature Methods, 2011, 8 : 18 - 18